Stay updated on BMS-986205 and Nivolumab in Liver Cancer Clinical Trial
Sign up to get notified when there's something new on the BMS-986205 and Nivolumab in Liver Cancer Clinical Trial page.

Latest updates to the BMS-986205 and Nivolumab in Liver Cancer Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedAdded Revision: v3.4.3 and removed Revision: v3.4.2.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check32 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2.SummaryDifference0.1%

- Check40 days agoChange DetectedThe page revision label was updated from v3.4.0 to v3.4.1, indicating a minor maintenance update that does not affect the study details.SummaryDifference0.1%

- Check47 days agoChange DetectedAdded a glossary toggle and displayed a new 'Last Update Submitted that Met QC Criteria' label, along with a 'No FEAR Act Data' notice and a 'Revision: v3.4.0' marker. Removed the older 'Last Update Submitted that met QC Criteria', the 'No FEAR Act data' label, and the 'Revision: v3.3.4' marker.SummaryDifference0.2%

- Check61 days agoChange DetectedAdded revision: v3.3.4 and removed v3.3.3, a minor maintenance update with no impact on study content or user interactions.SummaryDifference0.1%

- Check83 days agoChange DetectedAdded a Locations section listing California as a site. Removed the California Locations entry and the HHS Vulnerability Disclosure link; updated the revision to v3.3.3.SummaryDifference0.2%

Stay in the know with updates to BMS-986205 and Nivolumab in Liver Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BMS-986205 and Nivolumab in Liver Cancer Clinical Trial page.